表紙
市場調查報告書
商品編碼
1028945

癌症分子診斷的全球市場:COVID-19的成長及變化預測 (∼2030年)

Oncology Molecular Diagnostics Global Market Report 2021: COVID-19 Growth And Change To 2030

出版日期: 按訂單生產 | 出版商: The Business Research Company | 英文 175 Pages | 商品交期: 2-10個工作天內

價格
  • 全貌
  • 簡介
  • 目錄
簡介

本報告提供全球癌症分子診斷的市場調查,彙整市場定義和概要,新型冠狀病毒感染疾病 (COVID-19) 以及其他的市場影響因素分析,市場規模的轉變·預測,產品·技術·終端用戶·地區/主要國家等各種區分的明細,競爭環境,主要企業的簡介,未來展望等資料。

目錄

第1章 摘要整理

第2章 市場特徵

第3章 市場趨勢·市場策略

第4章 COVID-19的影響

第5章 市場規模·成長預測

  • 市場規模的轉變·預測
  • 市場成長的促進因素
  • 市場阻礙成長要素

第6章 市場分析·預測:各種區分

  • 各產品
    • 設備
    • 試劑
    • 其他
  • 各技術
    • 聚合酵素鏈鎖反應(PCR)
    • 原位雜交(ISH)
    • 等溫核酸擴增技術(INNAT)
    • 晶片·微陣列
    • 定序
    • 質譜分析
    • 轉錄介導擴增(TMA)
    • 其他
  • 各終端用戶
    • 醫院
    • 診斷中心
    • 學術·研究機關
    • 其他

第7章 市場分析·預測:各地各國

第8章 亞太地區市場分析·預測

  • 市場概要
  • 地區資訊·COVID-19的影響·市場資訊·背景資訊·政府措施·法律規章·機關&協會·租稅·投資·主要企業
  • 市場分析·預測:各產品
  • 市場分析·預測:各技術

第9章 中國市場分析·預測

第10章 印度市場分析·預測

第11章 日本市場分析·預測

第12章 澳洲市場分析·預測

第13章 印尼市場分析·預測

第14章 韓國市場分析·預測

第15章 西歐市場分析·預測

第16章 英國市場分析·預測

第17章 德國市場分析·預測

第18章 法國市場分析·預測

第19章 東歐市場分析·預測

第20章 俄羅斯市場分析·預測

第21章 北美市場分析·預測

第22章 美國市場分析·預測

第23章 南美市場分析·預測

第24章 巴西市場分析·預測

第25章 中東市場分析·預測

第26章 非洲市場分析·預測

第27章 競爭情形·企業簡介

  • 競爭情形
  • 企業簡介
    • Abbott Diagnostics
    • Becton Dickinson
    • Cepheid
    • Danaher Corporation
    • Beckman Coulter

第28章 主要M&A

第29章 未來展望·潛在性分析

第30章 附錄

目錄
Product Code: h970

Oncology Molecular Diagnostics Global Market Report 2021: COVID-19 Growth And Change to 2030 from The Business Research Company provides the strategists, marketers and senior management with the critical information they need to assess the global oncology molecular diagnostics market.

This report focuses on oncology molecular diagnostics market which is experiencing strong growth. The report gives a guide to the oncology molecular diagnostics market which will be shaping and changing our lives over the next ten years and beyond, including the markets response to the challenge of the global pandemic.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 12+ geographies.
  • Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market research findings.
  • Benchmark performance against key competitors.
  • Utilize the relationships between key data sets for superior strategizing.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order.

Where is the largest and fastest growing market for the oncology molecular diagnostics ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The Oncology Molecular Diagnostics market global report from The Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography. It places the market within the context of the wider oncology molecular diagnostics market, and compares it with other markets.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, the influence of the COVID-19 virus and forecasting its growth.
  • Market segmentations break down market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • Competitive landscape gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
  • The oncology molecular diagnostics market section of the report gives context. It compares the oncology molecular diagnostics market with other segments of the oncology molecular diagnostics market by size and growth, historic and forecast. It analyses GDP proportion, expenditure per capita, oncology molecular diagnostics indicators comparison.

Scope

Markets Covered:

1) By Product: Instruments; Reagents; Others

2) By Technology: Polymerase Chain Reaction (PCR); In-situ Hybridization (ISH); Isothermic Nucleic Acid Amplification Technology (INNAT); Chips & Microarrays; Sequencing; Mass Spectroscopy; Transcription Mediated Amplification (TMA); Others

3) By End User: Hospitals; Diagnostic Centers; Academic & Research Institutes; Others

Companies Mentioned: Abbott Diagnostics; Becton Dickinson; Cepheid; Danaher Corporation; Beckman Coulter

Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA

Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa

Time series: Five years historic and ten years forecast.

Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,

Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Table of Contents

1. Executive Summary

2. Oncology Molecular Diagnostics Market Characteristics

3. Oncology Molecular Diagnostics Market Trends And Strategies

4. Impact Of COVID-19 On Oncology Molecular Diagnostics

5. Oncology Molecular Diagnostics Market Size And Growth

  • 5.1. Global Oncology Molecular Diagnostics Historic Market, 2015-2020, $ Billion
    • 5.1.1. Drivers Of The Market
    • 5.1.2. Restraints On The Market
  • 5.2. Global Oncology Molecular Diagnostics Forecast Market, 2020-2025F, 2030F, $ Billion
    • 5.2.1. Drivers Of The Market
    • 5.2.2. Restraints On the Market

6. Oncology Molecular Diagnostics Market Segmentation

  • 6.1. Global Oncology Molecular Diagnostics Market, Segmentation By Product, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Instruments
  • Reagents
  • Others
  • 6.2. Global Oncology Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Polymerase Chain Reaction (PCR)
  • In-situ Hybridization (ISH)
  • Isothermic Nucleic Acid Amplification Technology (INNAT)
  • Chips & Microarrays
  • Sequencing
  • Mass Spectroscopy
  • Transcription Mediated Amplification (TMA)
  • Others
  • 6.3. Global Oncology Molecular Diagnostics Market, Segmentation By End User, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Hospitals
  • Diagnostic Centers
  • Academic & Research Institutes
  • Others

7. Oncology Molecular Diagnostics Market Regional And Country Analysis

  • 7.1. Global Oncology Molecular Diagnostics Market, Split By Region, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 7.2. Global Oncology Molecular Diagnostics Market, Split By Country, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

8. Asia-Pacific Oncology Molecular Diagnostics Market

  • 8.1. Asia-Pacific Oncology Molecular Diagnostics Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Oncology Molecular Diagnostics Market, Segmentation By Product, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 8.3. Asia-Pacific Oncology Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

9. China Oncology Molecular Diagnostics Market

  • 9.1. China Oncology Molecular Diagnostics Market Overview
  • 9.2. China Oncology Molecular Diagnostics Market, Segmentation By Product, Historic and Forecast, 2015-2020, 2020-2025F, 2030F,$ Billion
  • 9.3. China Oncology Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2015-2020, 2020-2025F, 2030F,$ Billion

10. India Oncology Molecular Diagnostics Market

  • 10.1. India Oncology Molecular Diagnostics Market, Segmentation By Product, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 10.2. India Oncology Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

11. Japan Oncology Molecular Diagnostics Market

  • 11.1. Japan Oncology Molecular Diagnostics Market, Segmentation By Product, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 11.2. Japan Oncology Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

12. Australia Oncology Molecular Diagnostics Market

  • 12.1. Australia Oncology Molecular Diagnostics Market, Segmentation By Product, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 12.2. Australia Oncology Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

13. Indonesia Oncology Molecular Diagnostics Market

  • 13.1. Indonesia Oncology Molecular Diagnostics Market, Segmentation By Product, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 13.2. Indonesia Oncology Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

14. South Korea Oncology Molecular Diagnostics Market

  • 14.1. South Korea Oncology Molecular Diagnostics Market, Segmentation By Product, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 14.2. South Korea Oncology Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

15. Western Europe Oncology Molecular Diagnostics Market

  • 15.1. Western Europe Oncology Molecular Diagnostics Market Overview
  • 15.2. Western Europe Oncology Molecular Diagnostics Market, Segmentation By Product, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 15.3. Western Europe Oncology Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

16. UK Oncology Molecular Diagnostics Market

  • 16.1. UK Oncology Molecular Diagnostics Market, Segmentation By Product, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 16.2. UK Oncology Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

17. Germany Oncology Molecular Diagnostics Market

  • 17.1. Germany Oncology Molecular Diagnostics Market, Segmentation By Product, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 17.2. Germany Oncology Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

18. France Oncology Molecular Diagnostics Market

  • 18.4. France Oncology Molecular Diagnostics Market, Segmentation By Product, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 18.5. France Oncology Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

19. Eastern Europe Oncology Molecular Diagnostics Market

  • 19.1. Eastern Europe Oncology Molecular Diagnostics Market Overview
  • 19.2. Eastern Europe Oncology Molecular Diagnostics Market, Segmentation By Product, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 19.3. Eastern Europe Oncology Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

20. Russia Oncology Molecular Diagnostics Market

  • 20.1. Russia Oncology Molecular Diagnostics Market, Segmentation By Product, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 20.2. Russia Oncology Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

21. North America Oncology Molecular Diagnostics Market

  • 21.1. North America Oncology Molecular Diagnostics Market Overview
  • 21.2. North America Oncology Molecular Diagnostics Market, Segmentation By Product, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 21.3. North America Oncology Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

22. USA Oncology Molecular Diagnostics Market

  • 22.1. USA Oncology Molecular Diagnostics Market Overview
  • 22.2. USA Oncology Molecular Diagnostics Market, Segmentation By Product, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 22.3. USA Oncology Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

23. South America Oncology Molecular Diagnostics Market

  • 23.1. South America Oncology Molecular Diagnostics Market Overview
  • 23.2. South America Oncology Molecular Diagnostics Market, Segmentation By Product, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 23.3. South America Oncology Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

24. Brazil Oncology Molecular Diagnostics Market

  • 24.1. Brazil Oncology Molecular Diagnostics Market, Segmentation By Product, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 24.2. Brazil Oncology Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

25. Middle East Oncology Molecular Diagnostics Market

  • 25.1. Middle East Oncology Molecular Diagnostics Market Overview
  • 25.2. Middle East Oncology Molecular Diagnostics Market, Segmentation By Product, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 25.3. Middle East Oncology Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

26. Africa Oncology Molecular Diagnostics Market

  • 26.1. Africa Oncology Molecular Diagnostics Market Overview
  • 26.2. Africa Oncology Molecular Diagnostics Market, Segmentation By Product, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 26.3. Africa Oncology Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

27. Oncology Molecular Diagnostics Market Competitive Landscape And Company Profiles

  • 27.1. Oncology Molecular Diagnostics Market Competitive Landscape
  • 27.2. Oncology Molecular Diagnostics Market Company Profiles
    • 27.2.1. Abbott Diagnostics
      • 27.2.1.1. Overview
      • 27.2.1.2. Products and Services
      • 27.2.1.3. Strategy
      • 27.2.1.4. Financial Performance
    • 27.2.2. Becton Dickinson
      • 27.2.2.1. Overview
      • 27.2.2.2. Products and Services
      • 27.2.2.3. Strategy
      • 27.2.2.4. Financial Performance
    • 27.2.3. Cepheid
      • 27.2.3.1. Overview
      • 27.2.3.2. Products and Services
      • 27.2.3.3. Strategy
      • 27.2.3.4. Financial Performance
    • 27.2.4. Danaher Corporation
      • 27.2.4.1. Overview
      • 27.2.4.2. Products and Services
      • 27.2.4.3. Strategy
      • 27.2.4.4. Financial Performance
    • 27.2.5. Beckman Coulter
      • 27.2.5.1. Overview
      • 27.2.5.2. Products and Services
      • 27.2.5.3. Strategy
      • 27.2.5.4. Financial Performance

28. Key Mergers And Acquisitions In The Oncology Molecular Diagnostics Market

29. Oncology Molecular Diagnostics Market Future Outlook and Potential Analysis

30. Appendix

  • 30.1. Abbreviations
  • 30.2. Currencies
  • 30.3. Research Inquiries
  • 30.4. The Business Research Company
  • 30.5. Copyright And Disclaimer